BD Collaborates with U.S. Government to Develop COVID-19 Diagnostics
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read More
Search Results for: point-of-care testing
Dotz Nano to Showcase Mega-Diagnostic Platform
Dotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.
Read More
BD Announces Shipments of OTC Rapid COVID-19 Test
Shipments are now available for the BD Veritor At-Home COVID-19 Test, an over-the-counter COVID-19 rapid antigen test.
Read More
Smart Bandage Detects Biomarkers for Chronic Wound Monitoring
The wearable VeCare sensor can detect multiple chronic wound biomarkers to facilitate timely, personalized wound management at the point of care.
Read More
Researchers Find Biomarker for Dementia
Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the blood that can indicate impending dementia.
Read More